#United States #Toronto #Xtalks #Cell Line Development #Biologics Production

Webinar Overview: Streamlining Cell Line Development for Faster Biologics Production

In the ever-evolving landscape of biotherapeutics, the efficiency of cell line development stands as a pivotal factor influencing both development timelines and product quality. With upcoming advancements in transposase-mediated integration technology, Xtalks is hosting an informative webinar titled "Streamlining Cell Line Development for Faster Biologics Production". This session aims to explore progressive strategies that not only optimize cell line development processes but also enhance the reliability of biologics production.

Webinar Details

The free event will take place on Wednesday, November 12, 2025, at 10 AM EST and will feature industry experts, Cláudia Soares from CDR-Life and Lynn Webster from ATUM. They will share insights into the latest innovations in cell line development, including the utilization of transposase to achieve stable and efficient integration of expression constructs into CHO-K1 cells.

Participants can expect a thorough discussion on:

• - Benefits of Transposase-Mediated Integration Technology: This advanced approach facilitates the stable and non-random integration of multiple expression constructs, significantly impacting productivity and maintaining structural integrity.
• - Regulatory Readiness and Product Stability: Key considerations that ensure compliance with regulatory standards, ultimately smoothing the transition from development to clinical manufacturing.
• - Upstream Process Development: The need for synergy between process development and biosafety efforts to mitigate risks throughout the production lifecycle.

Importance of Streamlined Development

Efficient cell line development remains an industry challenge, yet achieving high-yield expression systems without compromising product quality is crucial. As the webinar emphasizes, a well-structured development strategy can drastically influence the success of a biotherapeutic program. By beginning at stable pools, the production process can generate materials suitable for initial toxicology and preclinical studies at an accelerated pace.

Integrated Strategies for Success

Alongside the advancements in transposase technologies, the webinar will showcase integrated development strategies that facilitate collaboration across various disciplines within biotherapeutics. Discussions will cover:

• - The alignment of clone selection, process optimization, and downstream manufacturing—allowing for a seamless transfer of technology and improved scalability.
• - An emphasis on multidisciplinary collaboration that enhances program efficiency and addresses complex development targets that were previously deemed challenging to manage.

Register Now

Don't miss this opportunity to gather invaluable knowledge from industry leaders about optimizing cell line development for faster, more reliable biologics production. To register for the webinar, visit Xtalks;
we invite everyone in the biotech sector to participate in this enriching session, designed to guide professionals toward innovative solutions in biologics production.

For any inquiries, please contact Vera Kovacevic at +1 (416) 977-6555 x371 or email [email protected]

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational content and digital events in the life sciences sector, offering access to critical insights and expert opinions. Be a part of this transformative discussion and enhance your understanding of biotherapeutic production methodologies.